1 option
The protective arm of the renin angiotensin system : functional aspects and therapeutic implications / Thomas Unger, Ulrike M. Steckelings, Robson A.S. dos Santos.
- Format:
- Book
- Author/Creator:
- Unger, Th., author.
- Steckelings, Ulrike M., author.
- Santos, Robson A. S. dos (Robson Augusto Souza dos), author.
- Language:
- English
- Subjects (All):
- Renin-angiotensin system.
- Physical Description:
- 1 online resource (312 pages) : illustrations
- Edition:
- 1st ed.
- Place of Publication:
- Amsterdam, [Netherlands] : Academic Press, 2015.
- Summary:
- The Protective Arm of the Renin Angiotensin System: Functional Aspects and Therapeutic Implications is the first comprehensive publication to signal the protective role of a distinct part of the renin-angiotensin system (RAS), providing readers with early insight into a complex system which will become of major medical importance in the near.
- Contents:
- Front Cover
- The Protective Arm of the Renin-Angiotensin System: Functional Aspects and Therapeutic Implications
- Copyright
- Contents
- Contributors
- Chapter 1: The Angiotensin AT 2 Receptor: From Enigma to Therapeutic Target
- Introduction
- References
- Chapter 2: The AT 2 Receptor: Historical Perspective
- Background to the Early Involvement of Ciba-Geigy in the Angiotensin Field
- Two Ang II Receptor Subtypes
- Angiotensin II Receptor Nomenclature
- Early Research on the Role of the AT 2 Receptor
- Conclusion
- Chapter 3: Animal Models with a Genetic Alteration of AT 2 Expression
- Blood Pressure
- Cardiac Disease
- Vascular Disease
- Renal Disease
- Neural Disease
- Chapter 4: AT 2 Receptor Signaling: Solved and Unsolved
- AT 2 R Dimerization
- Proliferation and Differentiation
- Apoptosis
- Inflammation
- Fibrosis
- Solved and Unsolved Issues
- Chapter 5: AT 1 R - AT 2 R Cross Talk
- Cross Regulation of Angiotensin II Type 1 Receptor and the Angiotensin II Type 2 Receptor
- Functional Significance of the AT 1 R - AT 2 R Cross Talk
- Chapter 6: The Angiotensin AT 2 Receptor in Myocardial Infarction
- AT 2 Receptor Expression in the Heart
- Acute-Phase Postmyocardial Infarction
- Cardiac Function
- Bradykinin/Nitric Oxide System
- Intracellular Acidosis
- Tissue Regeneration
- Late-Phase Postmyocardial Infarction
- Cardiac Fibrosis
- Cardiac Hypertrophy
- Extracellular Matrix Degradation
- Chapter 7: AT 2 R, Vascular Effects, and Blood Pressure
- AT 2 Vasorelaxation: In Vitro Preclinical Studies
- Acute AT 2 R Vasodilatation/ BP Effects: In Vivo Preclinical Studies.
- Chronic AT 2 R Effects on BP: Preclinical Studies
- Human Vascular AT 2 R Function: Ex Vivo and In Vivo Studies
- AT 2 R Vasorelaxation: Why Is There no Translation into Antihypertensive Effects in Chronic Studies?
- Acknowledgments
- Chapter 8: AT 2 R in Nervous System
- AT 2 R Expression in CNS
- AT 2 R Expression in Neuronal Injury
- AT 2 R -Mediated Effects in CNS Cells
- AT 2 R in Peripheral Neuronal Injury
- AT 2 R Stimulation in Stroke
- AT 2 R in Spinal Cord Injury
- AT 2 R in Multiple Sclerosis
- AT 2 R in Traumatic Brain Injury
- Chapter 9: Roles of AT 2 R in Cognitive Function
- Preventive Effects of ARB on Cognitive Decline and Dementia
- Protection Against Ischemic Brain Damage by AT 2 R Stimulation
- Role of AT 2 R Stimulation in Cognitive Function
- Role of AT 2 R-Associated Proteins in Cognitive Function
- Chapter 10: The Protective Role of Angiotensin II ( AT 2) Receptors in Renal Disease: Molecular Mechanisms and Indications ...
- Renal AT 2 R Expression
- Findings from AT 2 R Knockout ( AT 2 KO) Mice
- AT 2 R -Mediated Signaling Pathways
- Renoprotective Mechanisms of AT 2 R Stimulation
- Inflammation and Oxidative Stress
- Fibrosis and Extracellular Matrix Accumulation
- AT 2 R -Mediated Modulation of Other RAS Components
- Additional Mechanisms Involved in AT 2 R -Mediated Renoprotection
- AT 2 R in Renal Disease Associated with Obesity/Diabetes
- Chapter 11: AT 2 Receptors and Natriuresis
- Renal Expression of AT 2 Rs
- AT 2 R Induction of Natriuresis: Initial Evidence
- Role of Angiotensin III in AT 2 R -Induced Natriuresis
- Nephron Sites and Mechanisms of AT 2 R -Induced Natriuresis via ANG III.
- AT 2 R -Dopamine D 1 -Like Receptor Interactions
- Physiological Significance of Renal AT 2 Rs in Renal Na + Excretion
- AT 2 R -Induced Natriuresis in Disease States
- AT 2 R Agonist Administration and Natriuresis
- Chapter 12: The Role of the AT 2 R in Vascular Remodeling
- The Theoretical Concept of the Role of AT 2 R in Vascular Remodeling
- AT 2 R and Hypertension-Induced Vascular Remodeling
- AT 2 R and Atherosclerosis
- AT 2 R and Aortic Aneurysm
- Chapter 13: The AT 2 Receptor and Inflammation
- AT 2 R Signaling in Inflammation
- Inflammation in Cardiovascular Disease and the Role of the AT 2 Receptor
- Atherosclerosis
- Myocardial Infarction: Heart Failure
- Stroke
- Renal Injury
- Inflammation in Autoimmune Disease and the Role of the AT 2 Receptor
- Conclusions
- Chapter 14: The AT 2 Receptor and Interacting Proteins (ATIPs) in Cancer
- The Renin-Angiotensin System and Cancer
- The AT 2 Receptor and Cancer
- AT 2 Receptor-Interacting Proteins (ATIPs) and Cancer
- Chapter 15: AT 2 R and Sympathetic Outflow
- AT 2 R Ontogeny in Rodent Brain
- Effect of AT 2 R Activation on Neuronal Electrophysiological Characteristics
- AT 2 R and Sympathetic Regulation in Normal States
- Effects of the AT 2 R on Sympathetic Outflow in Pathological Conditions and Therapeutic Potential
- Conclusion and Perspectives
- Chapter 16: Metabolic Effects of AT 2 R Stimulation in Adipose Tissue
- Metabolic Function of AT 2 R: The Lessons from ARBs
- Metabolic Function of AT 2 R: The Lessons from AT 2 R-Deficient Mice
- Metabolic Function of AT 2 R: Experiments with Direct AT 2 R Stimulation
- References.
- Chapter 17: Sex Differences in AT 2 R Expression and Action
- Basis for Sex Differences in Function
- AT 2 R Gene Mapping
- Hormonal Regulation of AT 2 R Expression
- Regulation of Arterial Pressure and Renal Function
- Arterial Pressure
- Kidney
- Evidence for a Differential Role for the AT 2 R in Other Disease Conditions
- Heart and Vascular Disease
- Neurological Disorders
- Reproduction
- Chapter 18: Discovery of Nonpeptide, Selective AT 2 Receptor Agonists
- Selective Drug-like AT 2 R Agonists from Nonpeptide, Nonselective AT 1 /AT 2 Receptor Ligands
- Selective Drug-like AT 2 R Agonists from the Nonselective Parent Peptide Ang II
- Conversion of AT 2 R Agonists to AT 2 R Antagonists
- Chapter 19: Angiotensin-Based Peptides as AT 2 R Agonists
- Endogenous Angiotensin Peptides
- Ang II
- Ang III
- Ang IV
- Ang 1-7
- Ang 1-9
- Synthetic Peptides
- CGP42112
- β -Amino-Acid-Substituted Angiotensin Peptides
- [Y] 6 -AII
- LP2-3 (dKcAng-(1-7))
- Novokinin
- Chapter 20: Potential Clinical Application of Angiotensin 2 Receptor Agonists
- Preclinical Testing
- Investigational New Drug Application
- Clinical Trials
- Potential Therapeutic Indications for AT 2 R Agonists
- Orphan Indications
- Marfan Syndrome
- Idiopathic Pulmonary Fibrosis
- Other Indications
- Chapter 21: Angiotensin-(1-7) and Mas: A Brief History
- Discovery of Mas: Is It a Proto-Oncogene?
- Functions of Mas: Is It an Ang II Receptor?
- Mas, Its Antisense RNA, and Imprinting
- Mas Expression
- Mas Functions: Mas-Deficient Mice
- Discovery of Ang-(1-7)
- Closing the Gap: Mas Is an Ang-(1-7) Receptor
- Chapter 22: Animal Models with a Genetic Alteration of the ACE2/Ang-(1-7)/Mas Axis
- Transgenic Animal Technology: A Brief Update
- Transgenic and KO Rodent Models of the ACE2/Ang-(1-7)/Mas Axis
- ACE2 Models
- ACE2 KO Mice
- Human ACE2 Overexpression in Mouse
- Human ACE2 Overexpression in the Mouse Brain
- Human ACE2 Overexpression in the Mouse Heart
- Human ACE2 Overexpression in Mouse Podocytes
- Human ACE2 Overexpression in the Rat Vascular Smooth Muscle
- Mas Models
- Mas-KO Mice
- Mas Overexpression in Retina
- Prolylcarboxypeptidase KO Mice
- Ang-(1-7) Models
- Transgenic Rats Overexpressing Ang-(1-7)
- Transgenic Mice and Rats Overexpressing Ang-(1-7) in the Heart
- Conclusions and Outlook
- Chapter 23: Mas Signaling: Resolved and Unresolved Issues
- Expression of Mas
- Mas as a GPCR
- Early Discovery of Mas and Its Signaling Pathways
- Identifying Ang-(1-7) Targets Through Proteomics
- Ang-(1-7)/Mas Signaling Through Akt
- Ang-(1-7)/Mas Signaling and Nitric Oxide Production
- Mas and MAPK Signaling
- Mas and RhoA
- Biological Significance of Mas Signaling: Insights from Mas-Knockout Mice
- Unresolved Issues
- Chapter 24: Mas/AT 2 Cross Talk
- Chapter 25: ACE2 Cell Biology, Regulation, and Physiological Functions
- ACE2: Discovery and Basic Biology
- ACE2 Regulation
- Chapter 26: Mas in Myocardial Infarction and Congestive Heart Failure
- Myocardial Infarction and Congestive Heart Failure
- Renin-Angiotensin System and Cardiac Remodeling
- Inflammatory Phase
- Proliferative Phase
- Maturation Phase
- Chapter 27: Mas Receptor: Vascular and Blood Pressure Effects
- Chapter 28: Mas and Neuroprotection in Stroke
- Introduction.
- Neuroprotection and the RAS.
- Notes:
- Includes bibliographical references at the end of each chapters and index.
- Description based on print version record.
- Description based on publisher supplied metadata and other sources.
- ISBN:
- 0-12-801364-8
- OCLC:
- 908074996
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.